Content about DUBLIN

August 1, 2013

Cardinal Health is significantly bullish heading into fiscal 2014. And for good reason. Not only does the graying of the baby boomers continue to represent a strong tailwind, but there are five other factors that will help fill those sails as well, George Barrett, Cardinal chairman and CEO, told investors Thursday morning.

July 10, 2013

Tria Beauty, a maker of laser and light-based skin care products, has announced the closing of $45.5 million in new equity financing and a new structured debt facility.

July 2, 2013

Covidien has finished spinning off its pharmaceuticals division, the medical products maker said.

June 14, 2013

Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.

May 29, 2013

Healthcare company Cardinal Health has released a series of studies showing ways that it says could reduce the cost of treating cancer.

May 23, 2013

Cardinal Health received the National Business Group on Health Platinum Best Employers for Healthy Lifestyles award for its ongoing commitment to promoting a healthy workplace and encouraging employees and their families to pursue and maintain healthy lifestyles.

May 22, 2013

Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.

May 20, 2013

Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.

May 14, 2013

A new infographic released Tuesday created by the Cardinal Health Foundation and The Ohio State University College of Pharmacy helps illustrate prescription drug abuse in the United States.

May 2, 2013

Cardinal Health reported fiscal year 2013 third-quarter revenue of $24.6 billion, a 8.9% decline as compared to the quarter a year ago.

April 25, 2013

Cardinal Health and McKesson separately announced the renewal of their pharmaceutical distribution agreements with CVS Caremark.

April 23, 2013

Cardinal Health's philanthropic division is offering grants to organizations for programs to prevent abuse and misuse of prescription drugs.

April 23, 2013

The Food and Drug Administration has approved a new contraceptive drug made by Warner Chilcott, the drug maker said.

April 17, 2013

Tria Beauty, a maker of light-based skin care products and technology, has inked a new partnership with beauty retailer Ulta.

April 16, 2013

The Food and Drug Administration has approved a new strength of an antibiotic made by Warner Chilcott, the drug maker said.

April 15, 2013

HealthSpot, a provider of telehealth technology, has been asked to present at the Consumer Electronics Association 2013 CES on the Hill, the company has announced.

April 10, 2013

With the growing concern of the abuse of prescription stimulants like Adderall on college campuses, the Cardinal Health Foundation and the Ohio State University College of Pharmacy introduced Generation Rx University, the fourth in a series of interactive toolkits designed to help reduce the abuse of prescription drugs.

March 19, 2013

In the wake of a new partnership announcement between Walgreens and AmerisourceBergen, Cardinal Health announced on that its pharmaceutical distribution contract with Walgreens that is scheduled to expire at the end of August 2013 will not be renewed.

March 13, 2013

Sephora is previewing the newest innovation of the Tria Hair Removal Laser for acne and the company's line of topical skin care products on Sephora.com.

February 14, 2013

Cardinal Health announced plans to acquire privately held AssuraMed, a provider of medical supplies to patients in the home, for $2.1 billion.

February 8, 2013

Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.

February 8, 2013

The Food and Drug Administration has approved a new drug from Warner Chilcott for treating ulcerative colitis, the drug maker said.

February 7, 2013

Cardinal Health announced it is providing free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing cardiovascular disease.

February 5, 2013

Cardinal Health posted $25.2 billion in revenue for its 2013 second quarter, down 7%. The company's non-GAAP diluted earnings per share was up 15% to $0.93.

© 2014 Drug Store News. All Rights Reserved.